Predictors of mortality in patients treated with ECMELLA after cardiac surgery – a single- center experience
Abstract Background Postcardiotomy cardiogenic shock (PCS) remains a serious complication after cardiac surgery associated with high perioperative mortality. Over the last years, the use of veno-arterial extracorporeal life support (VA-ECLS) combined with left ventricular unloading by a microaxial flow pump (ECMELLA) has increased. Data on mortality predictors in patients treated with ECMELLA for PCS remain limited. We aimed to identify factors associated with 30-day all-cause mortality after ECMELLA implantation. Methods We retrospectively analyzed consecutive patients who received concomitant VA-ECLS and a microaxial pump after cardiac surgery at our university center between 2019 and 2024. Clinically relevant surrogate parameters were assessed along with 30-day mortality. Discriminative ability was assessed by receiver operating characteristic (ROC) analysis. Survival was analyzed using Kaplan–Meier estimates with log-rank testing, and predictors of 30-day mortality were identified using univariable and multivariable Cox proportional hazards regression. Results Of the 34 patients, 26 (76.5%) died within 30 days. The Model for End-stage Liver Disease (MELD) score was significantly higher in non-survivors than in survivors (18.5 [IQR 10.7] vs. 14.9 [IQR 2.8], p = 0.010). The MELD excluding INR (MELD-XI) score was likewise higher in non-survivors (17.6 [IQR 9.7] vs. 10.2 [IQR 2.6], p = 0.001). Lactate levels were significantly lower in survivors at 12 hours (p = 0.03), 18 hours (p = 0.004) and 24 hours (p = 0.02) after ECMELLA initiation. Discrimination was best at 18 hours (AUC 0.824, p < 0.001). Aortic cross-clamp time was not associated with 30-day mortality when analyzed as a continuous variable; however, an exploratory cutoff of ≥ 63 minutes was associated with increased mortality (HR 3.20, 95% CI 1.34–7.65, p = 0.009). In univariable Cox regression, MELD-XI ≥ 12.5 (HR 2.87, 95% CI 1.13–7.32) and lactate ≥ 2 mmol/L at 18 hours (HR 4.47, 95% CI 1.48–13.52) were associated with 30-day mortality, but neither remained independently associated in multivariable analysis. Conclusions Biological markers, including MELD-XI and lactate, could provide complementary prognostic information before and after ECMELLA implantation, whereas the prognostic value of a prolonged aortic cross-clamp time, observed only in an exploratory threshold analysis, remains uncertain.
Authors
- Matthias F. Bechtel (ORCID: https://orcid.org/0000-0002-1393-1889)
- Dirk Buchwald
- Peter Lukas Haldenwang (ORCID: https://orcid.org/0000-0003-1884-3498)
- Vadim Moustafine
- Simon Becker (ORCID: https://orcid.org/0000-0001-7830-3616)
- Sebastian Loesaus
- Dinah Maria Berres (ORCID: https://orcid.org/0009-0008-2087-6348)
- Nizar Salah
- Peter Konrad Zahn
- Justus Thomas Strauch
Institutions
- Ruhr University Bochum (DE)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-14
- DOI
- https://doi.org/10.21203/rs.3.rs-11515982/v1
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- preprint